|
⚲
|
| Keyboard |
| Halpryn Glenn L
✚
|
|
|---|---|
| CIK # | 0000938439 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0000938439] | |
| SC 13G | [0000938439] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Halpryn Glenn L | Ladenburg Thalmann Financial Services Inc | [2019-02-11] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Niagen Bioscience Inc | |
| Halpryn Glenn L | |
| Castle Brands Inc | |
| Sorrento Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Niagen Bioscience Inc CDXC.OB
Employee Stock Options (right to buy) · derivative
|
2015-07-06 | Grant | 75,000 | $0.00 | |
|
Castle Brands Inc ROX
Stock Option (Right to Buy) · derivative
|
2015-03-26 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc CDXC.OB
Employee Stock Options (right to buy) · derivative
|
2014-06-18 | Grant | 75,000 | $0.00 | |
|
Castle Brands Inc ROX
Stock Option (Right to Buy) · derivative
|
2014-03-05 | Grant | 20,000 | $0.00 | |
|
Castle Brands Inc ROX
Common Stock
|
2014-02-24 | Option exercise | 850,834 | $0.30 | 255,250 |
|
Castle Brands Inc ROX
10% Series A Convertible Preferred Stock · derivative
|
2014-02-24 | Option exercise | 209.19 | $0.00 | |
|
Castle Brands Inc ROX
Common Stock
|
2014-02-21 | Option exercise | 344,066 | $0.38 | 130,745 |
|
Castle Brands Inc ROX
Common Stock Purchase Warrants · derivative
|
2014-02-21 | Option exercise | 344,066 | $0.00 | |
|
Niagen Bioscience Inc CDXC.OB
Common Stock
|
2014-01-21 | Grant | 10,000 | $0.00 | |
|
Castle Brands Inc ROX
5% Subordinated Convertible Note due 2018 · derivative
|
2013-10-31 | Grant | $200,000.00 | ||
|
Niagen Bioscience Inc CDXC.OB
Warrants to Purchase Common Stock · derivative
|
2013-02-12 | Option exercise | 535,714 | $0.00 | |
|
Niagen Bioscience Inc CDXC.OB
Common Stock
|
2013-02-12 | Option exercise | 535,714 | $0.21 | 112,500 |
|
Niagen Bioscience Inc CDXC.OB
Employee Stock Options (right to buy) · derivative
|
2012-12-21 | Disposed to issuer | 82,500 | $0.00 | |
|
Niagen Bioscience Inc CDXC.OB
Employee Stock Options (right to buy) · derivative
|
2012-12-21 | Disposed to issuer | 82,500 | $0.00 | |
|
Niagen Bioscience Inc CDXC.OB
Employee Stock Options (right to buy) · derivative
|
2012-12-21 | Grant | 106,809 | $0.00 | |
|
Castle Brands Inc ROX
Stock Option (Right to Buy) · derivative
|
2012-10-15 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc CDXC.OB
Employee Stock Options (right to buy) · derivative
|
2012-08-28 | Grant | 82,500 | $0.00 | |
|
Niagen Bioscience Inc CDXC.OB
Common Stock
|
2012-02-10 | Buy | 200,000 | $0.75 | 150,000 |
|
Sorrento Therapeutics Inc SRNE
Non-qualified stock option · derivative
|
2012-02-06 | Grant | 140,000 | $0.00 |